⌘K

Login Start Free

Home/Filings/4/0001062993-22-019645

4//SEC Filing

BEN-MAIMON CAROLE 4

Accession 0001062993-22-019645

CIK 0001374690other

View on SEC.gov Company Profile

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 7:00 AM ET

Size

4.8 KB

Accession

0001062993-22-019645

Insider Transaction Report

Form 4

Period: 2022-09-16

Larimar Therapeutics, Inc.LRMR

BEN-MAIMON CAROLE

DirectorPresident and CEO

Transactions

Purchase
Common Stock
2022-09-16$3.15/sh+31,746$100,000→ 56,829 total

Footnotes (1)

[F1]Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Larimar Therapeutics, Inc.

CIK 0001374690

Entity typeother

Related Parties

1

filerCIK 0001529611

Filing Metadata

Form type: 4
Filed: Sep 18, 8:00 PM ET
Accepted: Sep 19, 7:00 AM ET
Size: 4.8 KB

View on SEC.gov